InvestWiser

SoftOx Solutions AS

SOFTXOslo BørsHealthcareMarket value 298 m NOK
0.11NOK +8.5%
last day · Price as of 18 November 2026

The answer first

Does SoftOx Solutions beat the market?

Yes, SoftOx Solutions has beaten the market over the last year.

SoftOx Solutions+69.2%Oslo Børs (OSEBX)+30.8%
  • The ranking · Quality, value and trend combined

    Better than 30% of Nordic stocks

    • Quality34
    • Value4
    • Trend86

    No. 101 of 192 in healthcare

Max for seven days

Follow SoftOx Solutions with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on SoftOx Solutions

From today, at a price of 0.11 NOK. Write why you follow SoftOx Solutions, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about SoftOx Solutions

Your first answer is free, no account needed.

Do you own SoftOx Solutions, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with SoftOx Solutions and a few more. Free, no card.

Past year against the exchange and Super Stock
SoftOx Solutions+59.4%Oslo Børs (OSEBX)+30.8%Super Stock+45.9%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • SoftOx Solutions has risen 69.2% over the past year, including dividends.
  • Overall, SoftOx Solutions ranks better than 30% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 100.0%. The price is 99.9% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

30

Quality, value and trend together. Better than 30% of Nordic stocks.

No. 101 of 192 in healthcare

Quality34
The company · Fundamentals: the accounts

Medium An average company: the accounts are neither especially strong nor weak.

No. 152 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.60
  • Asset turnoverSales divided by everything the company owns0.46
  • Return on equityProfit divided by equity−47.1%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value4
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 169 of 194 in healthcareTypical in healthcare: 19Typical in the Nordics: 50

  • P/BPrice divided by equity11.9
  • P/SPrice divided by sales17.5
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend86
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 33 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+26.4%
  • 6 months−4.0%
  • 9 months+93.0%
  • 12 months+69.2%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−4.3%
3 years, per year
−70.3%
5 years, per year
−70.2%
Year to date
+25.3%
Largest fall, 3 years
−100.0%
From a peak to the bottom
From the peak now
−99.9%
How far the price is from the peak
Volatility, 1 year
111.2%
How much the price swings over a year
Beta, 1 year
1.66
How much the price moves when the market moves

Return with dividends reinvested.

About SoftOx Solutions

SoftOx Solutions AS is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 2 employees.

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx Solutions AS was founded in 2012 and is based in Lysaker, Norway.

See the full analysis of SoftOx Solutions.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Oslo Børs

Explore the stock market